Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 46Lung Neoplasms 26Carcinoma, Hepatocellular 22Small Cell Lung Carcinoma 17Urinary Bladder Neoplasms 11Cholangiocarcinoma 10Breast Neoplasms 10Biliary Tract Neoplasms 10Liver Neoplasms 9Neoplasms 8Neoplasm Metastasis 8Pancreatic Neoplasms 5Triple Negative Breast Neoplasms 4Non-Muscle Invasive Bladder Neoplasms 4Colorectal Neoplasms 4Carcinoma, Transitional Cell 4Carcinoma 4Stomach Neoplasms 3Respiratory Tract Neoplasms 3Ovarian Neoplasms 3Neoplasms by Site 3Gallbladder Neoplasms 3Endometrial Neoplasms 3Carcinoma, Renal Cell 3Bile Duct Neoplasms 3Adenocarcinoma 3Thyroid Neoplasms 2Thoracic Neoplasms 2Sarcoma 2Respiratory Tract Diseases 2

Interventions

Doxorubicin 14pembrolizumab 11Specimen Handling 11Magnetic Resonance Spectroscopy 10Biopsy 9Cyclophosphamide 8X-Rays 7Radiotherapy 7Nivolumab 7Ifosfamide 7Phantoms, Imaging 6Gemcitabine 6liposomal doxorubicin 5Temozolomide 5Radiation 5tazemetostat 4palbociclib 4Trabectedin 4Nuclear Medicine Department, Hospital 4Irinotecan 4Ipilimumab 4pazopanib 3larotrectinib 3fludarabine 3cabozantinib 3atezolizumab 3Surveys and Questionnaires 3Radiation Dose Hypofractionation 3Proton Therapy 3Carboplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sarcoma × durvalumab × 90 days × Clear all
NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed
603 enrolled
Sarcoma

Neoplasm Metastasis, Sarcoma

NCT04705818 2026-03-06

CAIRE

Institut Bergonié

Phase 2 Completed
164 enrolled
GastrointestinalSarcoma

Tertiary Lymphoid Structures, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡